Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans

被引：83

作者：

Uhl, Franziska M. ^{[1
,2
]}

Chen, Sophia ^{[1
,3
]}

O'Sullivan, David ^{[4
]}

Edwards-Hicks, Joy ^{[4
]}

Richter, Gesa ^{[5
]}

Haring, Eileen ^{[1
,2
]}

Andrieux, Geoffroy ^{[6
,7
,8
]}

Halbach, Sebastian ^{[9
]}

Apostolova, Petya ^{[1
,4
]}

Buscher, Jorg ^{[4
]}

Duquesne, Sandra ^{[1
]}

Melchinger, Wolfgang ^{[1
]}

Sauer, Barbara ^{[1
]}

Shoumariyeh, Khalid ^{[1
]}

Schmitt-Graeff, Annette ^{[10
]}

Kreutz, Marina ^{[11
,12
]}

Lubbert, Michael ^{[1
]}

Duyster, Justus ^{[1
]}

Brummer, Tilman ^{[7
,8
,9
]}

Boerries, Melanie ^{[6
,7
,8
]}

Madl, Tobias ^{[5
,13
]}

Blazar, Bruce R. ^{[14
]}

Gross, Olaf ^{[15
,16
,17
]}

Pearce, Erika L. ^{[4
]}

Zeiser, Robert ^{[1
,16
,17
]}

机构：

[1] Univ Freiburg, Fac Med, Med Ctr, Dept Internal Med 1, D-79106 Freiburg, Germany

[2] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany

[3] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Immunol, New York, NY 10065 USA

[4] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany

[5] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Mol Biol & Biochem, A-8010 Graz, Austria

[6] Univ Freiburg, Fac Med, Med Ctr, Inst Med Bioinformat & Syst Med, D-79110 Freiburg, Germany

[7] German Canc Consortium DKTK, Partner Site Freiburg, D-69120 Heidelberg, Germany

[8] German Canc Res Ctr, D-69120 Heidelberg, Germany

[9] Univ Freiburg, Fac Med, Inst Mol Med & Cell Res IMMZ, D-79104 Freiburg, Germany

[10] Univ Freiburg, D-79085 Freiburg, Germany

[11] Univ Hosp Regensburg, Internal Med 3, D-93042 Regensburg, Germany

[12] Regensburg Ctr Intervent Immunol RCI, D-93053 Regensburg, Germany

[13] BioTechMed Graz, A-8010 Graz, Austria

[14] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA

[15] Univ Freiburg, Fac Med, Med Ctr, Inst Neuropathol, D-79106 Freiburg, Germany

[16] Univ Freiburg, Signalling Res Ctr BIOSS, D-79106 Freiburg, Germany

[17] Univ Freiburg, CIBSS Ctr Integrat Biol Signalling Studies, D-79106 Freiburg, Germany

来源：

SCIENCE TRANSLATIONAL MEDICINE | 2020年 / 12卷 / 567期

基金：

欧洲研究理事会;

关键词：

ACUTE MYELOID-LEUKEMIA; HOST-DISEASE; RELAPSE; TRANSPLANTATION; SURVIVAL; INFUSIONS; THERAPY; IMPACT; PH;

D O I：

10.1126/scitranslmed.abb8969

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation (allo-HCT) has a dismal prognosis. We found that T cells of patients relapsing with AML after allo-HCT exhibited reduced glycolysis and interferon-gamma production. Functional studies in multiple mouse models of leukemia showed that leukemia-derived lactic acid (LA) interfered with T cell glycolysis and proliferation. Mechanistically, LA reduced intracellular pH in T cells, led to lower transcription of glycolysis-related enzymes, and decreased activity of essential metabolic pathways. Metabolic reprogramming by sodium bicarbonate (NaBi) reversed the LA-induced low intracellular pH, restored metabolite concentrations, led to incorporation of LA into the tricarboxylic acid cycle as an additional energy source, and enhanced graft-versus-leukemia activity of murine and human T cells. NaBi treatment of post-allo-HCT patients with relapsed AML improved metabolic fitness and interferon-y production in T cells. Overall, we show that metabolic reprogramming of donor T cells is a pharmacological strategy for patients with relapsed AML after allo-HCT.

引用

页数：14

共 50 条

[31] Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells
Coghill, James M.
Carlson, Michael J.
Panoskaltsis-Mortari, Angela
West, Michelle L.
Burgents, Joseph E.
Blazar, Bruce R.
Serody, Jonathan S.
BLOOD, 2010, 115 (23) : 4914 - 4922
[32] Notch inhibition enhances graft-versus-leukemia while reducing graft-versus-host disease
Luo, Xiaodan
Xu, Lihua
Liu, Lian
Li, Yangqiu
Tan, Huo
EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 843 : 226 - 232
[33] T-helper cells: Their role in the pathogenesis of graft-versus-host disease and graft-versus-leukemia effect
Bunjes, D
Theobald, M
Nierle, T
Hertenstein, B
Merk, B
Stefanic, M
Novotny, J
Arnold, R
Heimpel, H
BONE MARROW AND PERIPHERAL STEM CELL TRANSPLANTATION: MEDICAL PROBLEMS IN THE POSTTRANSPLANTATION PHASE AND REHABILITATION STRATEGIES, 1996, : 38 - 65
[34] Suicide gene transduced T-cells for the regulation of the graft-versus-leukemia effect
Bonini, C
Ciceri, F
Marktel, S
Bordignon, C
VOX SANGUINIS, 1998, 74 : 341 - 343
[35] Role of B Cells in Graft-Versus-Leukemia and Graft-Versus-Host Disease
Ritz, Jerome
BLOOD, 2013, 122 (21)
[36] T cells, graft-versus-host disease and graft-versus-leukemia: Innovative approaches for blood and marrow transplantation
Champlin, R
Giralt, S
Gajewski, J
ACTA HAEMATOLOGICA, 1996, 95 (3-4) : 157 - 163
[37] Donor T cells primed on leukemia lysate-pulsed recipient APCs mediate strong graft-versus-leukemia effects across MHC barriers in full chimeras
Ghosh, Arnab
Koestner, Wolfgang
Hapke, Martin
Schlaphoff, Verena
Laenger, Florian
Baumann, Rolf
Koenecke, Christian
Cornberg, Markus
Welte, Karl
Blazar, Bruce R.
Sauer, Martin G.
BLOOD, 2009, 113 (18) : 4440 - 4448
[38] Immunoregulatory cells for transplantation tolerance and graft-versus-leukemia effect
Imamura, M
Tanaka, J
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (03) : 188 - 194
[39] Ex vivo fucosylation enhances NK cell function in graft-versus-leukemia
Gong, H.
Ma, S.
Fu, J.
Wu, D.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1502 - 1502
[40] Immunoregulatory Cells for Transplantation Tolerance and Graft-versus-Leukemia Effect
Masahiro Imamura
Junji Tanaka
International Journal of Hematology, 2003, 78 : 188 - 194

← 1 2 3 4 5 →